| Research |
|
Protocolo M39021 An open label, randomized, multicenter phase III trial comparing CVP and Mabfhera to standard CVP chemotherapy in patients with previously untreated CD20 positive follicular lymphoma Dr™ Maria Manuel Borges Alves Dr™ Maria Emília Cortesão Protocolo 304820 Efficacy and safety of subsequent treatment with 90Y-ibritumomab tiuxetan versus no further treatment in patients with stage III or IV follicular non-Hodgkinπs lymphoma having achieved partial or complete remission after first line chemotherapy. A prospective, multicenter, randomized phase III clinical trial. Dr. Rui Afonso SPD422-403 Open Label Study to Compare the Safety, Efficacy and Tolerability of Anagrelide Hydrochloride Versus Hydroxyurea in High-Risk Essencial Thrombocythaemia Patients Shire Dr™ Adriana Teixeira Dr. Sérgio Almeida H6Q-MC-JCBJ ñ (Prelude) A Phase 3 Clinical Study to Investigate the Prevention Of Relapse In Lymphoma Using Daily Enzastaurin Lilly Dr™ Adriana Teixeira Dr. Rui Afonso STARS Surveillance On The Treatment of Anemia & A Retrospective Survey Amgen Dr™ Isabel de Sousa MK0991 Estudo Multicíntrico com Dupla Ocultação, Aleatorizado, Comparativo para Avaliar a Segurança, Tolerabilidade e Eficácia de 2 Regimes Posológicos de Caspofungina no Tratamento da CandidÌase Invasiva no Adulto. Merck Dr™ Ana Isabel Dr. SÈrgio Almeida 26866 138 MMY 2036 Velcade For Re-treatment of Multiple Patients Following na Initial Response to Velcade Janssen-Cilag Dr™. Adriana Teixeira 26866138 LYM 3001 Open Label Study of Velcade With Rituximab or Rituximab Alone Janssen Cilag Dr™ Adriana Teixeira Dr™ Isabel de Sousa CA 180 043 BMS 354825 Dazatinib Dr. Paulo Tavares |




